Sarcoidosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 On 30thDecember 2014
Summary The industry analysis specialist, has released its new report, “Sarcoidosis Therapeutics Pipeline Assessment and Market Forecasts to 2019�. The report is an essential source of information and analysis on the global Sarcoidosis Therapeutics market. The report identifies the key trends shaping and driving the global Sarcoidosis Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Sarcoidosis Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
You can buy this Report @ http://www.jsbmarketresearch.com/healthcaremedical/r-sarcoidosis-therapeutics-pipeline-assessment-and-market-forecasts135209 Scope The report provides information on the key drivers and challenges of the Sarcoidosis Therapeutics market. Its scope includes - Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Sarcoidosis Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019. - Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes. - Analysis of the current and future competition in the seven key countries Sarcoidosis Therapeutics market. - Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. - Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Sarcoidosis Therapeutics market. - Analysis of key recent licensing and partnership agreements in Sarcoidosis Therapeutics market
Reasons to buy The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the global Sarcoidosis Therapeutics market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Sarcoidosis Therapeutics market in future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. - What’s the next big thing in the global Sarcoidosis Therapeutics market landscape? – Identify, understand and capitalize Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Other industries we cover: • • • • • • • • •
Advertising and Media Automotive and Parts Consumer Goods Healthcare and Medical Finance and Banking Food and Beverages Travel and Tourism Textiles and Clothing SWOT Analysis
Discounts on Market Research Reports till 31st December, 2014 For more inquiries, contact at +91 - 998 729 5242 / contact@jsbmarketresearch.com Table of Content 2 Sarcoidosis Therapeutics - Introduction 2.1 Overview 2.2 Epidemiology 2.3 Etiology 2.4 Symptoms 2.4.1 Lung Related Symptoms 2.4.2 Lymph Node Related Symptoms 2.4.3 Spleen Related Symptoms 2.4.4 Liver Related Symptoms 2.4.5 Heart Related Symptoms 2.4.6 Brain and Nervous System Related Symptoms 2.4.7 Eyes Related Symptoms 2.4.8 Musculoskeletal System Related Symptoms 2.5 Diagnosis 2.5.1 Initial Examination 2.5.2 X-rays 2.5.3 Biopsy 2.5.4 Imaging Techniques Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
2.5.5 Other Tests Related to Lungs, Heart, Brain and Nervous System 2.6 Pathophysiology 2.7 Treatment and Management Pattern 2.8 GlobalData Pipeline Report Guidance 3 Sarcoidosis Therapeutics - Market Characterization 3.1 Sarcoidosis Therapeutics Market Size (2006-2011) - Global 3.2 Sarcoidosis Therapeutics Market Forecast (2011-2019) - Global 3.3 Sarcoidosis Therapeutics Market Size (2006-2011) - The US 3.4 Sarcoidosis Therapeutics Market Forecast (2011-2019) - The US 3.5 Sarcoidosis Therapeutics Market Size (2006-2011) - France 3.6 Sarcoidosis Therapeutics Market Forecast (2011-2019) - France 3.7 Sarcoidosis Therapeutics Market Size (2006-2011) - Germany 3.8 Sarcoidosis Therapeutics Market Forecast (2011-2019) - Germany 3.9 Sarcoidosis Therapeutics Market Size (2006-2011) - Italy 3.10 Sarcoidosis Therapeutics Market Forecast (2011-2019) - Italy 3.11 Sarcoidosis Therapeutics Market Size (2006-2011) - Spain 3.12 Sarcoidosis Therapeutics Market Forecast (2011-2019) - Spain 3.13 Sarcoidosis Therapeutics Market Size (2006-2011) - The UK 3.14 Sarcoidosis Therapeutics Market Forecast (2011-2019) - The UK 3.15 Sarcoidosis Therapeutics Market Size (2006-2011) - Japan 3.16 Sarcoidosis Therapeutics Market Forecast (2011-2019) - Japan 3.17 Drivers and Barriers for the Sarcoidosis Therapeutics Market 3.17.1 Drivers for the Sarcoidosis Therapeutics Market 3.17.2 Barriers for the Sarcoidosis Therapeutics Market 3.18 Opportunity and Unmet Need 3.19 Key Takeaway 4 Sarcoidosis Therapeutics - Competitive Assessment 4.1 Overview 4.2 Strategic Competitor Assessment 4.3 Product Profile for Major Marketed Products in the Sarcoidosis Therapeutics Market 4.3.1 Corticosteroids 4.3.2 Immunosuppressant Drugs 4.3.3 TNF-alpha Blockers 4.3.4 Miscellaneous Agents 4.4 Key Takeaway 5 Sarcoidosis Therapeutics - Pipeline Assessment 5.1 Overview 5.2 Strategic Pipeline Assessment 5.3 Sarcoidosis Therapeutics - Pipeline Analysis by Phase of Development Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
5.3.1 Sarcoidosis Therapeutics - Phase III Pipeline 5.3.2 Sarcoidosis Therapeutics - Phase II Pipeline 5.3.3 Sarcoidosis Therapeutics - Phase I Pipeline 5.4 Sarcoidosis Therapeutics - Pipeline by Mechanism of Action 5.5 Technology Trends Analytical Framework 5.6 Pipeline Drug Description 5.6.1 DasKloster 0112-01 5.6.2 Stelara (ustekinumab) 5.6.3 Simponi (golimumab) 5.7 Key Takeaway 6 Sarcoidosis Therapeutics - Clinical Trials Mapping 6.1 Clinical Trials by Region and Country 6.2 Clinical Trials by Phase of Clinical Development 6.3 Clinical Trials by Trial Status 6.4 Clinical Trials by Sponsors 6.5 Top Companies Participating in Sarcoidosis Clinical Trials 7 Sarcoidosis Therapeutics - Strategic Assessment 7.1 Key Events Impacting the Future Market 7.2 Future Market Competition Scenario 8 Sarcoidosis Therapeutics - Future Players 8.1 Introduction 8.2 Company Profiles 8.2.1 Mondobiotech Holding AG 8.2.2 Johnson & Johnson 8.2.3 Celgene Corporation 8.3 Key Takeaway 9 Sarcoidosis Therapeutics - Licensing and Partnership Deals 10 Sarcoidosis Therapeutics - Appendix 10.1 Definitions 10.2 Acronyms 10.3 Research Methodology 10.3.1 Coverage 10.3.2 Secondary Research 10.3.3 Forecasting 10.3.4 Primary Research 10.3.5 Expert Panel Validation 10.4 Contact Us 10.5 Disclaimer 10.6 Bibliography Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
List Of Tables Table 1: Sarcoidosis - Initial Therapy According to Organ and Clinical Status Table 2: Sarcoidosis Therapeutics Market, Global, Revenue ($m), 2006-2011 Table 3: Sarcoidosis Therapeutics Market, Global, Forecast ($m), 2011-2019 Table 4: Sarcoidosis Therapeutics Market, The US, Revenue ($m), 2006-2011 Table 5: Sarcoidosis Therapeutics Market, The US, Forecast ($m), 2011-2019 Table 6: Sarcoidosis Therapeutics Market, France, Revenue ($m), 2006-2011 Table 7: Sarcoidosis Therapeutics Market, France, Forecast ($m), 2011-2019 Table 8: Sarcoidosis Therapeutics Market, Germany, Revenue ($m), 2006-2011 Table 9: Sarcoidosis Therapeutics Market, Germany, Forecast ($m), 2011-2019 Table 10: Sarcoidosis Therapeutics Market, Italy, Revenue ($m), 2006-2011 Table 11: Sarcoidosis Therapeutics Market, Italy, Forecast ($m), 2011-2019 Table 12: Sarcoidosis Therapeutics Market, Spain, Revenue ($m), 2006-2011 Table 13: Sarcoidosis Therapeutics Market, Spain, Forecast ($m), 2011-2019 Table 14: Sarcoidosis Therapeutics Market, The UK, Revenue ($m), 2006-2011 Table 15: Sarcoidosis Therapeutics Market, The UK, Forecast ($m), 2011-2019 Table 16: Sarcoidosis Therapeutics Market, Japan, Revenue ($m), 2006-2011 Table 17: Sarcoidosis Therapeutics Market, Japan, Forecast ($m), 2011-2019 Table 18: Sarcoidosis Therapeutics - Phase III Clinical Pipeline, 2011 Table 19: Sarcoidosis Therapeutics - Phase II Clinical Pipeline, 2011 Table 20: Sarcoidosis Therapeutics - Phase I Clinical Pipeline, 2011 Table 21: Sarcoidosis Therapeutics, Global, Clinical Trials, 2011 Table 22: Sarcoidosis Therapeutics, Global, Clinical Trials by Phase, 2011 Table 23: Sarcoidosis Therapeutics, Global, Clinical Trials by Status of Development, 2011 Table 24: Sarcoidosis Therapeutics, Global, Overall Sponsors, 2011 Table 25: Sarcoidosis Therapeutics, Global, Prominent Sponsors, 2011 Table 26: Sarcoidosis Therapeutics, Global, Top Ten Companies by Phase, 2011 Table 27: Mondobiotech Holding AG - Sarcoidosis Pipeline, 2011 Table 28: Johnson & Johnson - Sarcoidosis Pipeline, 2011 Table 29: Celgene Corporation - Sarcoidosis Pipeline, 2011 Table 30: Sarcoidosis Therapeutics, Global, Deals, 2011
List Of Figures
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Figure 1: Sarcoidosis - Agents Involved in Etiology of Sarcoidosis Figure 2: Sarcoidosis - Involvement of Various Organs Figure 3: Sarcoidosis - Pathophysiology of Granulomas Formation Figure 4: Sarcoidosis Therapeutics Market, Global, Revenue ($m), 2006-2011 Figure 5: Sarcoidosis Therapeutics Market, Global, Forecast ($m), 2011-2019 Figure 6: Sarcoidosis Therapeutics Market, The US, Revenue ($m), 2006-2011 Figure 7: Sarcoidosis Therapeutics Market, The US, Forecast ($m), 2011-2019 Figure 8: Sarcoidosis Therapeutics Market, France, Revenue ($m), 2006-2011 Figure 9: Sarcoidosis Therapeutics Market, France, Forecast ($m), 2011-2019 Figure 10: Sarcoidosis Therapeutics Market, Germany, Revenue ($m), 2006-2011 Figure 11: Sarcoidosis Therapeutics Market, Germany, Forecast ($m), 2011-2019 Figure 12: Sarcoidosis Therapeutics Market, Italy, Revenue ($m), 2006-2011 Figure 13: Sarcoidosis Therapeutics Market, Italy, Forecast ($m), 2011-2019 Figure 14: Sarcoidosis Therapeutics Market, Spain, Revenue ($m), 2006-2011 Figure 15: Sarcoidosis Therapeutics Market, Spain, Forecast ($m), 2011-2019 Figure 16: Sarcoidosis Therapeutics Market, The UK, Revenue ($m), 2006-2011 Figure 17: Sarcoidosis Therapeutics Market, The UK, Forecast ($m), 2011-2019 Figure 18: Sarcoidosis Therapeutics Market, Japan, Revenue ($m), 2006-2011 Figure 19: Sarcoidosis Therapeutics Market, Japan, Forecast ($m), 2011-2019 Figure 20: Opportunity and Unmet Need in the Sarcoidosis Therapeutics Market, 2011 Figure 21: Strategic Competitor Assessment of the Marketed Products in Sarcoidosis Therapeutics, 2011 Figure 22: Sarcoidosis- Clinical Pipeline by Phase of Development (%), 2011 Figure 23: Sarcoidosis Therapeutics, Clinical Pipeline by Mechanism of Action (%), 2011 Figure 24: Technology Trends Analytics Framework, 2011 Figure 25: Technology Trends Analytics Framework - Description, 2011 Figure 26: Sarcoidosis Therapeutics, Global, Clinical Trials by Country, 2011 Figure 27: Sarcoidosis Therapeutics, Global, Clinical Trials by Phase (%), 2011 Figure 28: Sarcoidosis Therapeutics, Global, Clinical Trials by Status of Development (%), 2011 Figure 29: Sarcoidosis Therapeutics, Global, Overall Sponsors (%), 2011 Figure 30: Sarcoidosis Therapeutics, Global, Prominent Sponsors (%), 2011 Figure 31: Sarcoidosis Therapeutics, Global, Top Companies by Phase, 2011 Figure 32: Sarcoidosis Therapeutics Market, Drivers and Barriers, 2011 Figure 33: Implications for Future Market Competition in the Sarcoidosis Therapeutics Market, 2011 Figure 34: Sarcoidosis Therapeutics Market, Clinical Pipeline by Company, 2011 Figure 35: GlobalData Market Forecasting Model
Report Price: Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Licence Type
Price
$ 3995
Site Licence
$ 7990
Enterprise Wide Licence
$ 11985
Related Reports: Respiratory Syncytial Virus (RSV) Prophylactic - Pipeline Assessment and Market Forecasts to 2019 Vaginitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Clostridium difficile Infection (CDI) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Atherosclerosis or Coronary Artery Disease (CAD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Unstable Angina Therapeutics - Pipeline Assessment and Market Forecast to 2018 Venous Thromboembolism (VTE) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Pulmonary Embolism (PE) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Vitiligo Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Chronic Urticaria or Hives Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Peptic Ulcer Therapeutics- Pipeline Assessment and Market Forecasts to 2018
You can order this report by calling on +91 - 998 7295 242 or mail us your contact details at contact@jsbmarketresearch.com About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along with providing in-depth analysis though reports, JSB market research also provides regular Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
updates of the market though newsletters. Our reports are a well-researched work of market researchers with an extensive knowledge and a good level of market experience.
To know more on Sarcoidosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 http://www.jsbmarketresearch.com/healthcare-medical/r-sarcoidosistherapeutics-pipeline-assessment-and-market-forecasts-135209
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/